BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11316930)

  • 1. Neonatal leukemoid reaction and early development of bronchopulmonary dysplasia in a very low-birth-weight infant.
    Zanardo V; Magarotto M; Rosolen A
    Fetal Diagn Ther; 2001; 16(3):150-2. PubMed ID: 11316930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemoid reaction and bronchopulmonary dysplasia: a primary inflammatory mechanism?
    Zanardo V; Vedovato S; Trevisanuto D; Chiarelli S
    Pediatrics; 2005 Nov; 116(5):1260-1; author reply 1261. PubMed ID: 16264021
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between neonatal leukemoid reaction and bronchopulmonary dysplasia in low-birth-weight infants: a cross-sectional study.
    Zanardo V; Savio V; Giacomin C; Rinaldi A; Marzari F; Chiarelli S
    Am J Perinatol; 2002 Oct; 19(7):379-86. PubMed ID: 12442227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemoid reaction and chronic lung disease in infants with very low birth weight.
    Nakamura T; Ezaki S; Takasaki J; Itabashi K; Ogawa Y
    J Matern Fetal Neonatal Med; 2002 Jun; 11(6):396-9. PubMed ID: 12389655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of extremely low birth weight infants with leukemoid reaction.
    Hsiao R; Omar SA
    Pediatrics; 2005 Jul; 116(1):e43-51. PubMed ID: 15930185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
    Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD
    Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of leukemoid reactions in extremely preterm infants in a tertiary NICU from 2018-2021.
    Terry C; Kane D; Eogan M; McCallion N; Doyle E; Drew RJ
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2225115. PubMed ID: 37322830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium absorption in very low birth weight infants with and without bronchopulmonary dysplasia.
    Hicks PD; Rogers SP; Hawthorne KM; Chen Z; Abrams SA
    J Pediatr; 2011 Jun; 158(6):885-890.e1. PubMed ID: 21300373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmological morbidity in very-low-birthweight infants with bronchopulmonary dysplasia.
    Ajayi OA; Raval D; Lucheese N; Pildes RS
    J Natl Med Assoc; 1997 Oct; 89(10):679-83. PubMed ID: 9347682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor development at term of very low birthweight infants with bronchopulmonary dysplasia.
    Byrne PJ; Piper MC; Darrah J
    J Perinatol; 1989 Sep; 9(3):301-6. PubMed ID: 2809783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial.
    Finer NN; Carlo WA; Duara S; Fanaroff AA; Donovan EF; Wright LL; Kandefer S; Poole WK;
    Pediatrics; 2004 Sep; 114(3):651-7. PubMed ID: 15342835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological chorioamnionitis and neonatal leukemoid reaction in low-birth-weight infants.
    Zanardo V; Vedovato S; Trevisanuto DD; Suppiej A; Cosmi E; Fais GF; Chiarelli S
    Hum Pathol; 2006 Jan; 37(1):87-91. PubMed ID: 16360420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between leukemoid reaction and perinatal morbidity, mortality, and chorioamnionitis in low birth weight infants.
    Duran R; Ozbek UV; Ciftdemir NA; Acunaş B; Süt N
    Int J Infect Dis; 2010 Nov; 14(11):e998-1001. PubMed ID: 20851018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden infant death syndrome in infants with bronchopulmonary dysplasia.
    Werthammer J; Brown ER; Neff RK; Taeusch HW
    Pediatrics; 1982 Mar; 69(3):301-4. PubMed ID: 7199705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchopulmonary dysplasia in very and extremely low birth weight infants - analysis of selected risk factors.
    Kiciński P; Kęsiak M; Nowiczewski M; Gulczyńska E
    Pol Merkur Lekarski; 2017 Feb; 42(248):71-75. PubMed ID: 28258680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromotor outcomes in infants with bronchopulmonary dysplasia.
    Karagianni P; Tsakalidis C; Kyriakidou M; Mitsiakos G; Chatziioanidis H; Porpodi M; Evangeliou A; Nikolaides N
    Pediatr Neurol; 2011 Jan; 44(1):40-6. PubMed ID: 21147386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-4 and 13 concentrations in infants at risk to develop Bronchopulmonary Dysplasia.
    Baier RJ; Loggins J; Kruger TE
    BMC Pediatr; 2003 Aug; 3():8. PubMed ID: 12925236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endostatin concentration in cord plasma predicts the development of bronchopulmonary dysplasia in very low birth weight infants.
    Janér J; Andersson S; Kajantie E; Lassus P
    Pediatrics; 2009 Apr; 123(4):1142-6. PubMed ID: 19336373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.